Corleen M. Roche's most recent trade in Cg Oncology Inc. was a trade of 143,907 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cg Oncology Inc. | Corleen M. Roche | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 143,907 | 143,907 | - | - | Employee Stock Option (Right to Buy) | |
| Cg Oncology Inc. | Corleen M. Roche | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 93,600 | 93,600 | - | - | Stock Option (Right to Buy) | |
| Cg Oncology Inc. | Corleen M. Roche | CFO & Secretary | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 29 Jan 2024 | 2,000 | 2,000 | - | 19 | 38,000 | Common Stock |
| Cg Oncology Inc. | Corleen M. Roche | CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 492,920 | 492,920 | - | - | Stock Option | |
| Immunome Inc | Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 58,000 | 58,000 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 16,609 | 16,609 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) |